


The Invesco Perpetual European Equity Income Fund aims to generate a rising level of income, together with long-term capital growth investing primarily into European equities, excluding the UK.
| Name | % Net Assets |
|---|---|
| Roche | 7.5% |
| Koninklijke KPN | 4.6% |
| Novartis | 4.4% |
| Total | 3.6% |
| Thales | 3.6% |
| GDF Suez | 3.6% |
| Oesterreich Post | 3.5% |
| Vivendi Universal | 3.3% |
| Reed Elsevier | 2.9% |
| Banque Cantonale Vaudoise | 2.7% |
| Key | % Net Assets |
|---|---|
| 7.5% | |
| 4.6% | |
| 4.4% | |
| 3.6% | |
| 79.9% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 300.02p |
| Currency | GBP |
| Change | -0.24p |
| % | -0.08% |
| YTD change | 50.92p |
| YTD % | 20.44% |
| Fund Inception | 12/12/2007 |
|---|---|
| Fund Manager | n/a |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | n/a |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research